Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol.
Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes.
Acute disseminated encephalomyelitis secondary to serogroup B meningococcal vaccine.
Qualitative perspectives on aquatic exercise initiation and satisfaction among persons with multiple sclerosis.
Study Confirms Natalizumab Efficacy, Safety in Treating RRMS
The complement and immunoglobulin levels in NMO patients.
Mitochondrial STAT3 is negatively regulated by SOCS3 and upregulated after spinal cord injury.
Giving meaning to illness: An investigation of self-defining memories in patients with relapsing-remitting multiple sclerosis patients.
Clinical Heterogeneity of Guillain-Barré Syndrome in the Emergency Department: Impact on Clinical Outcome.
Minimal Clinically Important Difference of Berg Balance Scale in People With Multiple Sclerosis.
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society.
Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells.
Pathoetiology of multiple sclerosis: are we barking up the wrong tree?
Neurologic indications for therapeutic plasma exchange: 2011 update.
Paraparetic Guillain-Barré syndrome: Non-demyelinating reversible conduction failure restricted to the lower limbs.
Imbalance in multiple sclerosis and neuromyelitis optica: association with deep sensation disturbance.
The impact of multiple sclerosis severity on health state utility values: Evidence from Australia.
Infantile metachromatic leukodystrophy in an 18 month old girl.
PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption.
Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
Multiple sclerosis and vitamin D: an update.
Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
Neurotherapeutic Strategies for Multiple Sclerosis.
Considerations in the development of generic disease therapies for multiple sclerosis.

Pages